Dr. Green Services explains why late-summer timing can play an important role in preventing winter weeds before spring DALLAS, Aug. 20, 2026 /PRNewswire/ -- As North Texas moves toward fall, homeowners are approaching an important window for preventing winter weeds before they become...
Attorneys J.J. Dominguez, Tom Antunovich and Matthew Joy were recognized for their work in the field of Personal Injury Law - Plaintiffs. LOS ANGELES, Aug. 20, 2026 /PRNewswire/ -- The Dominguez Firm is proud to announce that three of its attorneys have been selected to the 2027 Best...
In accordance with section 30 of the Capital Markets Act, Pandora A/S hereby announces that Parvus European Opportunities Master Fund has notified the company that it now holds 3,717,821 shares, corresponding to 4.96% of the share capital in Pandora A/S, and has thereby fallen below the 5% threshold.
SOLANA BEACH, Calif., Aug. 20, 2026 (GLOBE NEWSWIRE) -- Artelo Biosciences, Inc. (Nasdaq: ARTL) (“Artelo” or the “Company”) , a clinical-stage pharmaceutical company focused on modulating lipid-signalling pathways to develop treatments for people living with cancer, pain, dermatologic, or neurological conditions, today announced that the Japanese Patent Office has issued a notification of allowance with a Decision to Grant for the Company’s patent application covering the intended commercial formulation of ART27.13, Artelo’s peripherally selective dual cannabinoid agonist currently being evaluated in two Phase 2 clinical trials.
Last week, the government of the Democratic Republic of the Congo (DRC) requested a release of Ervebo vaccines from the global Ebola virus disease vaccine stockpile, managed by the International Coordinating Group on Vaccine Provision (ICG). The request was for use of the vaccine in the current Bundibugyo virus disease outbreak. Ervebo vaccine is licensed and recommended for use in outbreaks of Ebola virus disease (previously called Zaire ebolavirus). On Monday, the ICG informed the DRC go... Read the full story at https://www.webwire.com/ViewPressRel.asp?aId=359192
JD Technologies Global will use their field sales expertise and established relationships to pursue new customers that will benefit MoovinV. Julie automates a large part of procurement processes, enabling buyers to focus on high-value activities. It includes powerful modules that boost...
- - • Major upgrades allow thyssenkrupp Steel to focus on high-margin premium products - • Substantial improvements in slab quality enable production of multi-phase, high-strength, and e-mobility steel grades - • Direct charging of slabs increases energy efficiency while preserving high quality in sensitive steel grades such as electrical silicon steels - - - In April 2026, thyssenkrupp Steel issued the final acceptance certificate (FAC) for continuous slab casting machine No.4 from... Read the full story at https://www.webwire.com/ViewPressRel.asp?aId=359190
(PR-inside.com) MINNEAPOLIS, MN / ACCESS Newswire / August 20, 2026 / Block & Leviton is investigating CVRx, Inc. (Nasdaq:CVRX) for potential securities law violations. Investors who have lost money in their CVRx, Inc. investment should contact the firm to learn more about how they might recover those losses. For more details, visit https://blockleviton.com/cases/cvrx. What is this all about? Block & Leviton is investigating whether CVRx and certain of its executives misrepresented or failed to timely disclose material information about the company's sales execution, growth, and revenue outlook. On August 6, 2026, CVRx cut its full-year revenue guidance to $58-60 million from a prior ..
HSE Creates a Dedicated Platform for Discovering New Partners and Emerging Capabilities: Connecting Suppliers and Solutions to Transform the Hardlines Marketplace LAS VEGAS, Aug. 20, 2026 /PRNewswire/ -- Trade shows help buyers find products, and the Hardlines Supplier Event (HSE) was...
Agiloft's customers can now benefit from code-free, CRM-native contract management to help you extend your Agentic Enterprise REDWOOD CITY, Calif., Aug. 20, 2026 /PRNewswire/ -- Agiloft, the global leader in data-first contract lifecycle management (CLM), today announced it has launched...
Experienced life sciences executive to expand access to high-quality, deeply annotated biospecimens supporting research and development of next-generation therapies BETHESDA, Md., Aug. 20, 2026 /PRNewswire/ -- Precision for Medicine, a global leader in biomarker-driven clinical research...
SAN ANTONIO, Aug. 20, 2026 /PRNewswire/ -- Elenova AI today launched as a consultancy that builds and deploys custom AI workflows for leasing, maintenance, and operations engineered and pressure-tested inside a live multifamily real estate portfolio, REEP Equity and REEP Residential,...